Vaxcyte, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 28, 2025: -7.10

Vaxcyte, Inc. Enterprise Value to EBITDA (EV/EBITDA) is -7.10 on July 28, 2025, a -57.59% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Vaxcyte, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -4.50 on July 28, 2025, which is 36.55% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Vaxcyte, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -35.81 on July 28, 2025, which is -404.53% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Vaxcyte, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -14.98.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization